References
- Martinon F, Tschopp J. Inflammatory caspases: linking an intracellular innate immune system to autoinflammatory diseases. Cell117, 561–574 (2004).
- Saleh M, Vaillancourt JP, Graham RK et al. Differential modulation of endotoxin responsiveness by human caspase-12 polymorphisms. Nature429, 75–79 (2004).
- Martinon F, Tschopp J. Inflammatory caspases and inflammasomes: master switches of inflammation. Cell Death Differ.14, 10–22 (2007).
- Kanneganti TD, Lamkanfi M, Nunez G. Intracellular NOD-like receptors in host defense and disease. Immunity27, 549–559 (2007).
- Grabbe S, Schwartz T. Immunoregulatory mechanisms involved in elicitation of allergic contact hypersensitivity. Immunol. Today19, 37–44 (1998).
- Nestle FO, Nickoloff BJ. Deepening our understanding of immune sentinels in the skin. J. Clin. Invest.117, 2382–2385 (2007).
- Zaba LC, Fuentes-Duculan J, Steinman RM et al. Normal human dermis contains distinct populations of CD11c+BDCA-1+ dendritic cells and CD163+FXIIIA+ macrophages. J. Clin. Invest.117, 2517–2525 (2007).
- Bos JD, De Rie MA, Teunissen MB et al. Psoriasis: dysregulation of innate immunity. Br. J. Dermatol.152, 1098–1107 (2005).
- Henseler T, Christophers E. Disease concomitance in psoriasis. J. Am. Acad. Dermatol.32, 982–986 (1995).
- Lamkanfi M, Declerq W, Berghe TV et al. Caspases leave the beaten track: caspase-mediated activation of NF-κB. J. Cell Biol.173, 165–171 (2006).
- Yamin TT, Ayala JM, Miller DK. Activation of the native 45-kDa precursor form of interleukin-1-converting enzyme. J. Biol. Chem.271, 13273–13282 (1996).
- Hentze H, Lin XY, Choi MS et al. Critical role for cathepsin B in mediating caspase-1-dependent interleukin-18 maturation and caspase-1-independent necrosis triggered by the microbial toxin nigericin. Cell Death Differ.10, 956–968 (2003).
- Schmitz J, Owyang A, Oldham E et al. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity23, 479–490 (2005).
- Thomberry NA, Bull HG, Calaycay JR et al. A novel heterodimeric cysteine protease is required for interleukin-1β processing in monocytes. Nature356, 768–774 (1992).
- Li P, Allen H, Banerjee S et al. Mice deficient in IL-1 β-converting enzyme are defective in production of mature IL-1β and resistant to endotoxic shock. Cell80, 401–411 (1995).
- Kuida K, Lippke JA, Ku G et al. Altered cytokine export and apoptosis in mice deficient in interleukin-1β converting enzyme. Science267, 2000–2003 (1995).
- Gu Y, Kuida K, Tsutsui H et al. Activation of interferon-γ inducing factor mediated by interleukin-1β converting enzyme. Science275, 206–209 (1997).
- Ghayur T, Banerjee S, Hugunin M et al. Caspase-1 processes IFN-γ-inducing factor and regulates LPS-induced IFN-γ production. Nature386, 619–623 (1997).
- Sansonetti PJ, Phalipon A, Arondel J et al. Caspase-1 activation of IL-1β and IL-18 are essential for Shigella flexneri-induced inflammation. Immunity22, 669–677 (2000).
- Tsuji NM, Tsutsui H, Seki E et al. Roles of caspase-1 in Listeria infection in mice. Int. Immunol.16, 335–343 (2004).
- Mariathasan S, Weiss DS, Dixit VM et al. Innate immunity against Francisella tularensis is dependent on the ASC/caspase-1 axis. J. Exp. Med.202, 1043–1049 (2005).
- Miura M, Zhu H, Rotello R et al. Induction of apoptosis in fibroblasts by IL-1 β-converting enzyme, a mammalian homolog of the C. elegans cell death gene ced-3. Cell75, 653–660 (1993).
- Gurcel L, Abrami L, Girardin S et al. Caspase-1 activation of lipid metabolic pathways in response to bacterial pore-forming toxins promotes cell survival. Cell126, 1135–1145 (2006).
- Muhl H, Pfeilschifter J. Interleukin-18 bioactivity: a novel target for immunopharmacological anti-inflammatory intervention. Eur. J. Pharmacol.500, 63–71 (2004).
- Koizumi H, Sato-Matsumura KC, Nakamura H et al. Distribution of IL-18 and IL-18 receptor in human skin: various forms of IL-18 are produced in keratinocytes. Arch. Dermatol. Res.293, 325–333 (2001).
- Wang S, Miura M, Jung YK et al. Murine caspase-11, an ICE-interacting protease, is essential for the activation of ICE. Cell92, 501–509 (1998).
- Ahn EY, Pan G, Vickers SM et al. IFN-γ upregulates apoptosis-related molecules and enhances Fas-mediated apoptosis in human cholangiocarcinoma. Int. J. Cancer100, 445–451 (2002).
- Schwartz S Jr, Yamamoto H, Navarro M et al. Frameshift mutations at mononucleotide repeats in caspase-5 and other target genes in endometrial and gastrointestinal cancer of the microsatellite mutator phenotype. Cancer Res.59, 2995–3002 (1999).
- Lin XY, Choi MS, Porter AG. Expression analysis of the human caspase-1 subfamily reveals specific regulation of the CASP5 gene by lipopolysaccharide and interferon-γ. J. Biol. Chem.275, 39920–39926 (2000).
- Yamamoto M, Yaginuma K, Tsutsui H et al. ASC is essential for LPS-induced activation of procaspase-1 independently of TLR-associated signal adaptor molecules. Genes Cells9, 1055–1067 (2004).
- Martinon F, Burns K, Tschopp J. The inflammasome: molecular platform triggering activation of inflammatory caspases and processing of proIL-β. Mol. Cell10, 417–426 (2002).
- Masumoto J, Taniguchi S, Nakayama J et al. Expression of apoptosis-associated speck-like protein containing a caspase recruitment domain, a pyrin N-terminal homology domain-containing protein, in normal human tissues. J. Histochem. Cytochem.49, 1269–1275 (2001).
- Shiohara M, Taniguchi S, Masumoto J et al. ASC, which is composed of a PYD and a CARD, is up-regulated by inflammation and apoptosis in human neutrophils. Biochem. Biophys. Res. Commun.293, 1314–1318 (2002).
- Church LD, Cook GP, McDermott MF. Primer: inflammasomes and interleukin-1β in inflammatory disorders. Nat. Clin. Pract. Rheumatol.4, 34–42 (2008).
- Shinkai K, McCalmont TH, Leslie KS. Cryopyrin-associated periodic syndromes and autoinflammation. Clin. Exp. Dermatol.33, 1–9 (2008).
- Agostini L, Martinon F, Burns K et al. NALP3 forms an IL-1β-processing inflammasome with increased activity in Muckle–Wells autoinflammatory disorder. Immunity20, 319–325 (2004).
- Gattorno M, Tassi S, Carta S et al. Pattern of interleukin-1β secretion in response to lipopolysaccharide and ATP before and after interleukin-1 blockade in patients with CIAS1 mutations. Arthritis Rheum.56, 3138–3148 (2007).
- Hawkins PN, Lachmann HJ, Aganna E et al. Spectrum of clinical features in Muckle–Wells syndrome and response to anakinra. Arthritis Rheum.50, 607–612 (2004).
- Hoffman HM, Rosengren S, Boyle DL et al. Prevention of cold-associated acute inflammation in familial cold autoinflammatory syndrome by interleukin-1 receptor antagonist. Lancet364, 1779–1785 (2004).
- Hysi P, Kabesch M, Moffatt MF et al. NOD1 variation, immunoglobulin E and asthma. Hum. Mol. Genet.14, 935–941 (2005).
- Hugot JP, Chamaillard M, Zouali H et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn’s disease. Nature411, 599–603 (2001).
- Rosengren S, Hoffman HM, Bugbee W et al. Expression and regulation of cryopyrin and related proteins in rheumatoid arthritis synovium. Ann. Rheum. Dis.64, 708–714 (2005).
- Martinon F, Petrilli V, Mayor A et al. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature440, 237–241 (2006).
- Ohta Y, Hamada Y, Katsuoka K. Expression of IL-18 in psoriasis. Arch. Dermatol. Res.293, 334–342 (2001).
- Companjen A, van der Wel L, van der Fits L et al. Elevated interleukin-18 protein expression in early active and progressive plaque-type psoriatic lesions. Eur. Cytokine Netw.15, 210–216 (2004).
- Camp RD, Fincham NJ, Cunningham FM et al. Psoriatic skin lesions contain biologically active amounts of an interleukin 1-like compound. J. Immunol.137, 3469–3474 (1986).
- Gruaz D, Didierjean L, Grassi J et al. Interleukin 1α and β in psoriatic skin: enzymoimmunoassay, immunoblot studies and effect of systemic retinoids. Dermatologica179, 202–206 (1989).
- Feldmeyer L, Keller M, Niklaus G et al. The inflammasome mediates UVB-induced activation and secretion of interleukin-1β by keratinocytes. Curr. Biol.17, 1140–1145 (2007).
- Wang B, Feliciani C, Howell BG et al. Contribution of Langerhans cell-derived IL-18 to contact hypersensitivity. J. Immunol.168, 3303–3308 (2002).
- Watanabe H, Gaide O, Petrilli V et al. Activation of the IL-1β-processing inflammasome is involved in contact hypersensitivity. J. Invest. Dermatol.127, 1956–1963 (2007).
- Raymond AA, Méchin MC, Nachat R et al. Nine procaspases are expressed in normal human epidermis, but only caspase-14 is fully processed. Br. J. Dermatol.156, 420–427 (2007).
- Johansen C, Moeller K, Kragballe K et al. The activity of caspase-1 is increased in lesional psoriatic epidermis. J. Invest. Dermatol.127, 2857–2864 (2007).
- Kummer JA, Broekhuizen R, Everett H et al. Inflammasome components NALP 1 and 3 show distinct but separate expression profiles in human tissues suggesting a site-specific role in the inflammatory response. J. Histochem. Cytochem.55, 443–452 (2007).
- Mizutani H, Black R, Kupper TS. Human keratinocytes produce but do not process pro-interleukin-1 (IL-1) β. Different strategies of IL-1 production and processing in monocytes and keratinocytes. J. Clin. Invest.87, 1066–1071 (1991).
- Antonopoulos C, Cumberbatch M, Dearman RJ et al. Functional caspase-1 is required for Langerhans cell migration and optimal contact sensitization in mice. J. Immunol.166, 3672–3677 (2001).
- Sutterwala FS, Ogura Y, Szczepanik M et al. Critical role for NALP3/CIAS1/Cryopyrin in innate and adaptive immunity through its regulation of caspase-1. Immunity24, 317–327 (2006).
- Yazdi AS, Ghoreschi K, Röcken M. Inflammasome activation in delayed-type hypersensitivity reactions. J. Invest. Dermatol.127, 1853–1856 (2007).
- Shimizu H, Banno Y, Sumi N et al. Activation of p38 mitogen-activated protein kinase and caspases in UVB-induced apoptosis of human keratinocyte HaCaT cells. J. Invest. Dermatol.112, 769–774 (1999).
- Wang M, Tsai BM, Turrentine MW et al. p38 mitogen activated protein kinase mediates both death signaling and functional depression in the heart. Ann. Thorac. Surg.80, 2235–2241 (2005).
- Sekiyama A, Ueda H, Kashiwamura S et al. A stress-induced, superoxide-mediated caspase-1 activation pathway causes plasma IL-18 upregulation. Immunity22, 669–677 (2005).
- Kumar S, Boehm J, Lee JC. p38 MAP kinases: key signaling molecules as therapeutic targets for inflammatory diseases. Nat. Rev. Drug Discov.2, 717–726 (2003).
- Johansen C, Kragballe K, Westergaard M et al. The mitogen-activated protein kinases p38 and ERK1/2 are increased in lesional psoriatic skin. Br. J. Dermatol.152, 37–42 (2005).
- Johansen C, Funding AT, Otkjaer K et al. Protein expression of TNF-α in psoriatic skin is regulated at a posttranscriptional level by MAPK-activated protein kinase 2. J. Immunol.176, 1431–1438 (2006).
- Funding AT, Johansen C, Kragballe K et al. Mitogen- and stress-activated protein kinase 2 and cyclic AMP response element binding protein are activated in lesional psoriatic epidermis. J. Invest. Dermatol.127, 2012–2019 (2007).
- Funding AT, Johansen C, Kragballe K et al. Mitogen- and stress-activated protein kinase 1 is activated in lesional psoriatic epidermis and regulates the expression of pro-inflammatory cytokines. J. Invest. Dermatol.126, 1784–1791 (2006).
- Mariathasan S, Newton K, Monack DM et al. Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf. Nature430, 213–218 (2004).
- Yamanaka K, Tanaka M, Tsutsui H et al. Skin-specific caspase-1-transgenic mice show cutaneous apoptosis and pre-endotoxin shock condition with a high serum level of IL-18. J. Immunol.165, 997–1003 (2000).